Kyle Salyers is a Co-founder and Managing Director of CHV Capital, Inc. (CHV), a wholly owned venture capital affiliate of Indiana's largest integrated delivery network, Indiana University Health. Kyle is the lead investor and a Director or Board Observer for NICO Corporation, MindFrame, NeoChord, Celleration, Perfect Serve, Noxilizer and MedVentive.
Mr. Salyers brings an integrated set of experiences and success as an entrepreneur, an investor, an economic development professional, and as a political staff member. As an investor, Mr. Salyers co-managed the venture activities of Rose-Hulman Ventures, an affiliate of Rose-Hulman Institute of Technology, in over 30 technology based start-up companies which included Suros Surgical Systems. Suros was acquired by Hologic in 2006 and provided Rose-Hulman Institute the single largest non-grant cash infusion in the institution’s history.
Mr. Salyers has played leadership roles in developing and funding a number of large scale public/ private economic development partnerships. As the Economic Development Manager for Indianapolis Mayor Stephen Goldsmith, he was instrumental in establishing the City’s first technology-based economic development plan: The Mayor’s High Technology Task Force and later served as the Vice President of the Indiana Technology Partnership.
As the Senior Vice President for Innovation & New Ventures at Thomas P. Miller & Associates (TPMA), Kyle led economic development and technology commercialization for many high profile clients including Purdue University. During his tenure TPMA was recognized as one of Central Indiana’s top 10 fastest growing private businesses for three consecutive years.
In 2005, the President of Indiana University engaged Mr. Salyers to develop the University’s first comprehensive economic development strategy, Advancing Indiana and serve as a Special Advisor and Executive Director of the Advancing Indiana initiative.
Mr. Salyers is the acting Chair of the Indiana University School of Nursing National Advisory Board and serves on the Board of Directors of TechPoint, and the Advisory Board of the Eiteljorg Museum of Native American and Western Art.
Mr. Salyers is a graduate of DePauw University with degrees in Economics and Sociology and was a four year varsity basketball player. Mr. Salyers has an MBA from the University of Notre Dame and completed Harvard University’s Making Corporate Boards More Effective executive education program. Kyle and his wife Natasha have three daughters.
Dr. Kun Ma has knowledge of both business and science.
Dr. Ma has worked for Indiana University Research and Technology Corporation, managed numerous technologies in biopharma/life science field, negotiated and maintained deals with a broad range of companies from startups to multinationals. He also worked for Tripos, Inc. as a Market Research Analyst and a Financial Analyst. He helped the marketing group to segment the market for the company's computational chemistry products and services and optimized marketing strategy. He also conducted full-scale company valuation, and evaluated gaps between the results and the market cap to help make financial and business strategies. Dr. Ma also worked for Zystor Therapeutics, Inc., an early stage biotech company, and developed a strategic plan of preclinical and clinical trials for the company's pipeline of large molecules, incorporating regulatory requirements, development timeline, and financial requirements. He also held a research position at the National Laboratory of Molecular Virology and Genetic Engineering, an institution devoted to research and commercialization of large-molecule therapeutics for infectious diseases, immune diseases and cancers.
Dr. Ma has a Ph.D. in Biochemistry and Molecular Biology from Indiana University, an MBA in Marketing and Strategy from the Olin School of Business of Washington University in St. Louis, and a MD from Beijing Medical University.
He resides in Indianapolis with his wife and two children.